Advances in diagnosis and therapeutic technologies have brought increased life expectancy for most cancers, but paradoxically it
also has increased the risk of second primary malignancies. Cancer survivors have a higher risk of developing cancer than the general
population. This suggests that more studies are needed to develop screen and management programs for cancer survivors, especially
patients with gastrointestinal cancers, which are the most common cancers in Korea.